At Capnia, we are developing and commercializing innovative diagnostics and devices, designed to help the smallest patients overcome their biggest obstacles.

Capnia has developed the CoSense® End-Tidal Carbon Monoxide Monitor that measures end-tidal carbon monoxide (ETCO) for the detection of dangerous hemolysis rates. Non-invasive hemolysis detection has important applications for the neonatology market, and newborn care will be an initial commercial focus for the product.